Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease

被引:50
|
作者
McNeal-Davidson, Ariane [1 ]
Fournier, Anne [1 ]
Spigelblatt, Linda [4 ]
Saint-Cyr, Claire [2 ]
Mir, Thomas S. [7 ]
Nir, Amiram [8 ]
Dallaire, Frederic [5 ,6 ]
Cousineau, Jocelyne [3 ]
Delvin, Edgard [3 ]
Dahdah, Nagib [1 ]
机构
[1] Univ Montreal, Dept Pediat, Div Pediat Cardiol, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Dept Pediat, Div Pediat Rhumatol & Immunol, Montreal, PQ H3C 3J7, Canada
[3] Univ Montreal, St Justine Univ Hosp Ctr, Dept Clin Biochem, Montreal, PQ H3C 3J7, Canada
[4] Maisonneuve Rosemont Hosp, Dept Pediat, Montreal, PQ, Canada
[5] Laval Univ Hosp Ctr, Dept Pediat, Div Pediat Cardiol, Quebec City, PQ, Canada
[6] Univ Laval, Quebec City, PQ, Canada
[7] Hamburg Eppendorf Univ Hosp, Clin & Polyclin Pediat Cardiol, Hamburg, Germany
[8] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel
关键词
echocardiography; incomplete criteria; incomplete Kawasaki disease; mucocutaneous lymph node syndrome; NT-proBNP; AMERICAN-HEART-ASSOCIATION; GAMMA-GLOBULIN; CARDIOVASCULAR-DISEASE; PEDIATRIC POPULATION; DIASTOLIC FUNCTION; ACUTE-PHASE; CHILDREN; BRAIN; STATEMENT; YOUNG;
D O I
10.1111/j.1442-200X.2012.03609.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The aim of the present study was to investigate the diagnostic value of the N-terminal B-type natriuretic peptide (NT-proBNP) in acute Kawasaki disease (KD) given that the clinical criteria and the current basic laboratory tests lack the necessary specificity for accurate diagnosis. Methods: Basic biological tests and serum NT-proBNP levels obtained from acute KD patients were compared to that of febrile controls. NT-proBNP was considered abnormal based on the following definitions: above a cut-off determined on receiver operator characteristic (ROC) analysis, above the upper limit for age, or above 2 SD calculated from healthy children. Analyses were also performed for KD cases with complete or incomplete criteria combined and separately. Results: There were 81 patients and 49 controls aged 3.60 +/- 2.77 versus 4.25 +/- 3.88 years (P= 0.69). ROC analysis yielded significant area under the curve for NT-proBNP. The sensitivity, specificity, positive and negative predictive values were 70.488.9%, 69.491.8%, 82.893.4%, and 65.279.1%. The odds ratios based on NT-proBNP definitions varied between 18.13 (95% confidence interval [CI]: 7.2145.57), 20.82 (95%CI: 8.1853.0), and 26.71 (95%CI: 8.6482.57; P < 0.001). Results were reproducible for cases with complete or incomplete criteria separately. Conclusion: NT-proBNP is a reliable marker for the diagnosis of KD. Prospective clinical studies with emphasis on NT-proBNP in a diagnostic algorithm are needed.
引用
收藏
页码:627 / 633
页数:7
相关论文
共 50 条
  • [1] Amino-Terminal Pro-B-Type Natriuretic Peptide in Refractory Kawasaki Disease
    de Benedictis, Fernando Maria
    Colaneri, Massimo
    Osimani, Patrizia
    Bettuzzi, Maria Grazia
    PEDIATRIC CARDIOLOGY, 2009, 30 (06) : 837 - 839
  • [2] Amino-Terminal Pro-B-Type Natriuretic Peptide in Refractory Kawasaki Disease
    Fernando Maria de Benedictis
    Massimo Colaneri
    Patrizia Osimani
    Maria Grazia Bettuzzi
    Pediatric Cardiology, 2009, 30
  • [3] Alterations of natriuretic peptides amino-terminal pro B-type natriuretic peptide and amino-terminal pro C-type natriuretic peptide during the pregnancy
    Tekin, Yesim Bayoglu
    Guven, Emine Seda Guvendag
    Kirbas, Aynur
    Cobanoglu, Ugur
    Colak, Sabri
    Dogan, Osman Deniz
    Sahin, Figen Kir
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2014, 27 (11): : 1103 - 1107
  • [4] Amino-terminal pro-B-type natriuretic peptide testing in renal disease
    DeFilippi, Christopher
    van Kimmenade, Roland R. J.
    Pinto, Yigal M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (3A): : 82A - 88A
  • [5] Use of amino-terminal pro-B-type natriuretic peptide to predict coronary disease
    Vickery, S
    Lamb, EJ
    John, RI
    Abbas, NA
    Webb, MC
    Price, CP
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (01) : 194 - 195
  • [6] Amino-terminal pro-B-type natriuretic peptide: Analytic considerations
    Ordonez-Llanos, Jordi
    Collinson, Paul O.
    Christenson, Robert H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (3A): : 9A - 15A
  • [7] Understanding amino-terminal pro-B-type natriuretic peptide in obesity
    Bayes-Genis, Antoni
    DeFilippi, Christopher
    Januzzi, James L., Jr.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (3A): : 89A - 94A
  • [8] Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation
    Giannopoulos, Georgios
    Kossyvakis, Charalampos
    Angelidis, Christos
    Efremidis, Michael
    Panagopoulou, Vasiliki
    Letsas, Konstantinos
    Bouras, Georgios
    Vassilikos, Vassilios P.
    Goudevenos, John
    Tousoulis, Dimitrios
    Lekakis, John
    Deftereos, Spyridon
    HEART RHYTHM, 2015, 12 (07) : 1470 - 1475
  • [9] Use of amino-terminal pro-B-type natriuretic peptide to predict coronary disease - Reply
    deFilippi, CR
    Christenson, R
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (01) : 195 - 196
  • [10] Amino-Terminal Pro-B-Type Brain Natriuretic Peptide: Screening for Cardiovascular Disease in the Setting of Alcoholism
    Hoefer, Peter
    Syeda, Bonni
    Bergler-Klein, Jutta
    Friedrich, Fabian
    Lesch, Otto Michael
    Vyssoki, Benjamin
    Binder, Thomas
    Walter, Henriette
    ALCOHOL AND ALCOHOLISM, 2011, 46 (03): : 247 - 252